investment

News

Novo Nordisk's site in Clayton, North Carolina

Novo Nordisk pledges $4.1bn for US injectables plant

Novo Nordisk has gone up another gear in its drive to boost manufacturing capacity for its fast-growing GLP-1 agonist drugs, announcing plans to build a $4.1 billion fill-and-finish facilit

News

AstraZeneca unveils plan for $1.5bn ADC plant in Singapore

AstraZeneca is backing up its considerable investment in antibody-drug conjugates (ADCs) for cancer with the construction of a $1.5 billion new facility in Singapore to ma

R&D

FT US Pharma and Biotech Summit: Live coverage

This week, pharmaphorum heads to the Big Apple for the FT US Pharma and Biotech Summit, a one-day event where executives from some of the world’s top pharma companies will come together to

Market Access

The UK vs. superbugs: Combatting AMR on the homefront

AMR, or antimicrobial resistance, is never far from the conversation these days.

R&D

London’s life sciences scene upbeat as 2024 conference seaso...

With 2024 well under way, influential conferences in London have given a barometer reading on the conditions in the European biopharma market, reports Richard Staines.

R&D

Green shoots and cautious optimism: Insights from BIO-Europe...

With thousands of pharma and biotech dealmakers attending last months’ BIO-Europe Spring, appetite for partnering looked alive and well.